Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical
company developing multifunctional biotherapeutics, today announced that
it will host a webcast and conference call to discuss progress on its
2019 corporate priorities, including clinical development plans for its
lead therapeutic candidates as well as recently announced and
established corporate partnerships.
Webcast and Conference Call Details
Zymeworks will host a webcast and conference call on Wednesday, May 29,
2019 at 8:30am ET (5:30am PT).
Interested parties can access the live webcast via a link from
Zymeworks’ website at http://ir.zymeworks.com/events-and-presentations
or join the live call and Q&A by dialing 1-800-319-4610 for North
American callers, or 1-604-638-5340 for international callers. Callers
should dial in five to 10 minutes prior to the scheduled start time and
ask to join the “Zymeworks call”.
A recorded replay will also be available on the website shortly after
the call concludes.
About Zymeworks Inc.
Zymeworks is a clinical-stage biopharmaceutical company dedicated to the
development of next-generation multifunctional biotherapeutics. The
Company’s suite of therapeutic platforms and its fully integrated drug
development engine enable precise engineering of highly differentiated
product candidates. Zymeworks’ lead clinical candidate, ZW25, is a novel
Azymetric™ bispecific antibody currently in Phase 2 clinical
development. The Company’s second clinical candidate, ZW49, is a
bispecific antibody-drug conjugate currently in Phase 1 clinical
development and combines the unique design and antibody framework of
ZW25 with Zymeworks’ proprietary ZymeLink™ cytotoxic payload. Zymeworks
is also advancing a deep preclinical pipeline in immuno-oncology and
other therapeutic areas. In addition, its therapeutic platforms are
being leveraged through strategic partnerships with nine
biopharmaceutical companies. For more information, visit www.zymeworks.com.
Cautionary Note Regarding Forward Looking Statements
This press release includes “forward-looking statements” within the
meaning of the U.S. Private Securities Litigation Reform Act of 1995 and
“forward-looking information” within the meaning of Canadian securities
laws, or collectively, forward-looking statements. Forward-looking
statements in this news release include statements that relate the
Company’s intention to host webcast and conference call, the timing of
such call and the topics to be discussed and other information that is
not historical information. When used herein, words such as “will”,
“plans”, “ongoing”, “progress” and similar expressions are intended to
identify forward-looking statements. In addition, any statements or
information that refer to expectations, beliefs, plans, projections,
objectives, performance or other characterizations of future events or
circumstances, including any underlying assumptions, are
forward-looking. All forward-looking statements are based upon
Zymeworks’ current expectations and various assumptions. Zymeworks
believes there is a reasonable basis for its expectations and beliefs,
but they are inherently uncertain. Zymeworks may not realize its
expectations, and its beliefs may not prove correct. Actual results
could differ materially from those described or implied by such
forward-looking statements as a result of various factors, including,
without limitation, market conditions and the factors described under
“Risk Factors” in Zymeworks’ Quarterly Report on Form 10-Q for the three
month period ended March 31, 2019 (a copy of which may be obtained at www.sec.gov
and www.sedar.com).
Consequently, forward-looking statements should be regarded solely as
Zymeworks’ current plans, estimates and beliefs. You should not place
undue reliance on forward-looking statements. Zymeworks cannot guarantee
future results, events, levels of activity, performance or achievements.
Zymeworks does not undertake and specifically declines any obligation to
update, republish, or revise any forward-looking statements to reflect
new information, future events or circumstances, or to reflect the
occurrences of unanticipated events, except as may be required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190523005807/en/
Copyright Business Wire 2019